FOXD2 and neoplasm: MiR-760 (Figure 3A) was found to contain a sequence complementary to FOXD2-AS1, and this miRNA was selected for verification because miR-760 exerts tumor-suppressive actions in a variety of human cancers (Hu et al., 2016; Liao et al., 2016; Cao et al., 2018; Yan et al., 2018).